Harbourvest Partners’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-751
| Closed | -$6.57K | – | 36 |
|
|
2024
Q2 | $6.57K | Hold |
751
| – | – | ﹤0.01% | 39 |
|
|
2024
Q1 | $18.4K | Hold |
751
| – | – | 0.01% | 47 |
|
|
2023
Q4 | $12.5K | Hold |
751
| – | – | ﹤0.01% | 52 |
|
|
2023
Q3 | $14K | Hold |
751
| – | – | ﹤0.01% | 57 |
|
|
2023
Q2 | $18.2K | Hold |
751
| – | – | 0.01% | 57 |
|
|
2023
Q1 | $16.4K | Hold |
751
| – | – | 0.01% | 62 |
|
|
2022
Q4 | $17.9K | Hold |
751
| – | – | 0.01% | 64 |
|
|
2022
Q3 | $21K | Hold |
751
| – | – | 0.01% | 67 |
|
|
2022
Q2 | $23K | Hold |
751
| – | – | 0.01% | 62 |
|
|
2022
Q1 | $40K | Hold |
751
| – | – | 0.01% | 66 |
|
|
2021
Q4 | $223K | Hold |
751
| – | – | 0.03% | 62 |
|
|
2021
Q3 | $291K | Hold |
751
| – | – | 0.03% | 49 |
|
|
2021
Q2 | $383K | Buy |
+751
| New | +$383K | 0.04% | 41 |
|